India Diabetes Care Market, By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, FY2026
The diabetes care market is segmented based on Diabetes type, Product type, End User, Region, and Company. Based on product type, the market can be split into diabetes drug and diabetes care devices. Among these, the diabetes drug segment is expected to dominate the market during the forecast period owing to their widespread use for all diabetes type. Based on diabetes type, the market can be fragmented into diabetes type 1, diabetes type 2 and gestational diabetes. Here, the most prevalent diabetes type is type 1. Furthermore, the glucose monitoring devices segment is expected to exhibit the highest growth on account of increasing diabetic cases. The self-monitoring devices are still dominating the market because they are relatively easier to use and cheaper.
Novo Nordisk India Private Limited, Sanofi India Limited, Eli Lilly India Pvt. Ltd., Roche Diagnostics India Pvt Ltd., Abbott India Limited, Becton Dickinson Private Limited, Johnson & Johnson Private Limited, India Medtronic Pvt. Ltd., Ypsomed India Private Ltd. and Novartis India Ltd are some of the companies operating in the India diabetes care market.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022FY2026
Objective of the Study:
To analyze the historical growth in the market size of India diabetes care market from FY2016 to FY2020.
To estimate and forecast the market size of India diabetes care market from FY2021 to FY2026 and growth rate until FY2026.
To classify and forecast India diabetes care market based on by product type, by diabetes type, by end use, company and region.
To identify dominant region or segment in the India diabetes care market.
To identify drivers and challenges for India diabetes care market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India diabetes care market.
To conduct pricing analysis for India diabetes care market.
To identify and analyze the profile of leading players operating in India diabetes care market.
To identify key sustainable strategies adopted by market players in India diabetes care market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of India diabetes care market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Manufacturers, distributors and end users
Market research and consulting firms
Government bodies such as regulating authorities and policy makers.
Organizations, forums, and alliances related to diabetes care.
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, India diabetes care market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
India Diabetes Care Market, By Type
oDiabetes Care Devices
oDiabetes Drugs Market
India Diabetes Care Market, By Diabetes Type
oType 1 Diabetes
oType 2 Diabetes
India Diabetes Care Market, By End User
oHome Care Settings
India Diabetes Care Market, By Region
Company Profiles: Detailed analysis of the major companies present in India diabetes care market.
With the given market data, TechSci Research offers customizations according to a companys specific needs. The following customization options are available for the report:
Detailed analysis and profiling of additional market players (up to five).
3.Impact of COVID-19 on India Diabetes Care Market
5.Voice of Customers/Customer Insights
6.India Diabetes Care Market Outlook
6.1.Market Size & Forecast
6.2.Market Share & Forecast
6.2.1.By Product Type (Diabetes Drugs vs. Diabetes Care Devices)
6.2.2.By Type of Diabetes (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)
6.2.3.By End User (Home Care Settings, Hospitals, Clinics)
6.2.4.By Region (North, South, East, West)
6.3.Product Market Map
7.India Diabetes Care Devices Market Outlook
7.1.Market Size & Forecast
7.2.Market Share & Forecast
7.2.1.By Product Type (Self-Monitoring Glucose Devices and Continuous Glucose Monitoring Devices)
7.2.2.By Type of Diabetes
7.2.3.By End User
8.India Diabetes Drugs Market Outlook
8.1.Market Size & Forecast
8.2.Market Share & Forecast
8.2.1.By Product Type (Insulin, Dipeptidyl peptidase-4 (DPP-4) inhibitors, Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), Others (Sodium-glucose co-transporter-2 (SGLT2) inhibitors, Biguanides, Sulfonylureas))
8.2.2.By Type of Diabetes
8.2.3.By End User
10.Market Trends & Developments
11.Policy & Regulatory Landscape
12.India Economic Profile
13.1.Company Profiles (Top 10 companies including Diabetes Care Devices and Diabetes Drugs Market)
13.1.1.Novo Nordisk India Private Limited
13.1.2.Sanofi India Limited
13.1.3.Eli Lilly India Pvt. Ltd.
13.1.4.Roche Diagnostics India Pvt Ltd.
13.1.5.Abbott India Limited
13.1.6.Becton Dickinson Private Limited
13.1.7.Johnson & Johnson Private Limited
13.1.8.India Medtronic Pvt. Ltd.
13.1.9.Ypsomed India Private Ltd.
13.1.10.Novartis India Ltd.
15.About Us & Disclaimer
List Of FiguresFigure 1: India Diabetes Care Market Size, By Value (USD Million), FY2016-FY2026
Figure 2: India Diabetes Care Market Share, By Product Type, By Value, FY2016-FY2026
Figure 3: India Diabetes Care Market Share, By Type of Diabetes, By Value, FY2016-FY2026
Figure 4: India Diabetes Care Market Share, By End User, By Value, FY2016-FY2026
Figure 5: India Diabetes Care Market Share, By Region, By Value, FY2016-FY2026
Figure 6: India Diabetes Care Market Share, By Company, By Value, FY2016-FY2026
Figure 7: India Diabetes Care Devices Market Size, By Value (USD Million), FY2016-FY2026
Figure 8: India Diabetes Care Devices Market Share, By Product Type, By Value, FY2016-FY2026
Figure 9: India Diabetes Care Devices Market Share, By Type of Diabetes, By Value, FY2016-FY2026
Figure 10: India Diabetes Care Devices Market Share, By End User, By Value, FY2016-FY2026
Figure 11: India Diabetes Drugs Market Size, By Value (USD Million), FY2016-FY2026
Figure 12: India Diabetes Drugs Market Share, By Product Type, By Value, FY2016-FY2026
Figure 13: India Diabetes Drugs Market Share, By Type of Diabetes, By Value, FY2016-FY2026
Figure 14: India Diabetes Drugs Market Share, By End User, By Value, FY2016-FY2026
Figure 15: Total number of diabetic patients in India, FY2016-FY2026
Figure 16: Total number of diabetic patients in India, By Age Group, FY2020
Figure 17: Total number of diabetic patients in India, By Gender, FY2020
Figure 18: Total number of patients suffering from Type 1 diabetes in India, FY2016-FY2026
Figure 19: Total number of patients suffering from Type 2 diabetes in India, FY2016-FY2026
Figure 20: Total number of patients suffering from Gestational diabetes in India, FY2016-FY2026
India Oxygen Concentrators Market By Type (Portable v/s Stationary), By Technology (Continuous Flow, Pulse Flow, Continuous/Pulse Flow), By Flow-rate (0-5l/min, 5-10l/min, Above 10l/min), By Source (Import v/s Domestic), By Distribution Channel (Wholesalers/Distributors/Suppliers, Online, Direct Sales), By Offering (Rental v/s New Sales), By Application (COPD, Lung Cancer, Asthma, COVID-19, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Home Care), By Region, Competition Forecast & Opportunities, FY2027F
India oxygen concentrators market stood at USD78.89 million in FY2021. The market is expected to witness robust growth in FY2022 due to the sudden surge in COVID-19 cases in theView Report
2021 India Database of Blood Typing, Grouping and Infectious Disease NAT Screening Market--Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs andView Report
Diabetes Care Devices Global Market Report 2021: COVID 19 Implications And Growth to 2030 from The Business Research Company covers this critical market and the impact on it from theView Report
Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The companys product portfolio includes t:slim X2 insulin pump, basal-IQ technology, softwareView Report
Fill The Form For Sample Request